AI is about to change healthcare. These 31 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
To be a shareholder in Opera today, you need to believe the company can translate premium, AI-driven browser products like Opera Neon into higher-margin revenue, especially as differentiation and pricing power become more critical in a saturated browser market. While the recent Neon launch signals Opera’s intent to capture professional users, its immediate impact on accelerating near-term user growth is uncertain, and the most pressing risk remains Opera’s dependence on third-party AI providers, which could alter costs and margin structure if licensing terms or technology access shift.
Among Opera’s recent announcements, the ongoing partnership with Google Cloud to integrate advanced AI elements is highly relevant to Neon. This collaboration enables Opera to embed capabilities such as image generation and enhance real-time experiences, supporting Neon’s ambition as a productivity-focused, subscription-based browser and aligning closely with the company’s most important catalyst: leveraging AI to increase engagement and monetization.
However, investors should also be mindful that Opera’s agentic AI approach exposes the business to a very different kind of cost pressure and competitive risk that...
Read the full narrative on Opera (it's free!)
Opera's outlook anticipates $813.6 million in revenue and $135.8 million in earnings by 2028. This scenario relies on 13.6% annual revenue growth and a $55.2 million increase in earnings from the current $80.6 million.
Uncover how Opera's forecasts yield a $25.50 fair value, a 39% upside to its current price.
Seven different fair value estimates from the Simply Wall St Community range from US$20.41 to US$47.69, highlighting strong disparity in growth expectations. With Opera’s AI-driven Neon launch relying on external model providers, the plurality of views invites you to weigh both new product potential and persistent dependency risks.
Explore 7 other fair value estimates on Opera - why the stock might be worth just $20.41!
Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.
Don't miss your shot at the next 10-bagger. Our latest stock picks just dropped:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com